Pfizer’s anti-Covid drug approved

China’s drug regulator granted conditional approval for Pfizer’s drug Paxlovid on Saturday. Paxlovid is effective against ongoing COVID-19 infections and attenuates its progression. The drug is approved in China for the treatment of adults with mild to moderate illness. Further studies are required to allow for unrestricted approval, the agency said.